Literature DB >> 5508376

Complement fixation by a two-component antibody system: immunoglobulin G and immunoglobulin M anti-globulin (rheumatoid factor). Parodoxical effect related to immunoglobulin G concentration.

F R Schmid, I M Roitt, M J Rocha.   

Abstract

Complement-mediated lysis of sheep erythrocytes coated with optimal concentrations of rabbit IgG hemolysin was inhibited by euglobulin fractions from the sera of patients with seropositive rheumatoid arthritis. That this was due to direct interaction with the IgG coat on the red cell rather than a nonspecific reaction with complement in the fluid phase was confirmed by controls using cells coated with IgM hemolysin. The inhibitory activity was recovered in purified IgM rheumatoid factor preparations and could be absorbed out with insoluble aggregated human IgG. The inhibitory potency of the rheumatoid factors correlated well with their sheep cell agglutination titers. Inhibition was not the result of physical aggregation of the erythrocytes by rheumatoid factor. Kinetic studies were consistent with the view that rheumatoid factor displaces C1q from its binding to IgG. Paradoxically, at suboptimal sensitizing concentrations of IgG hemolysin, rheumatoid factor enhances the fixation of complement. These results can be interpreted on the basis of the blockage of complement fixation by IgG and its replacement by a relatively weak direct fixation by the IgM rheumatoid factor. Thus, the interaction of RF with IgG generates only a limited ability to fix complement which, when contrasted with the fixation at suboptimal concentrations of IgG hemolysin alone, appears as net enhancement; when this is contrasted with fixation occurring with optimal concentrations of IgG, it appears as net inhibition.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5508376      PMCID: PMC2138859          DOI: 10.1084/jem.132.4.673

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

1.  Isolation of a thermolabile serum protein which precipitates gamma-globulin aggregates and participates in immune hemolysis.

Authors:  H J MULLER-EBERHARD; H G KUNKEL
Journal:  Proc Soc Exp Biol Med       Date:  1961-02

2.  Effects of rheumatoid factor on complement levels in vivo.

Authors:  W W Gough; J S Davis
Journal:  Arthritis Rheum       Date:  1966-08

3.  Relation of intracytoplasmic inclusions in joint fluid leukocytes to anti-gamma-G globulins.

Authors:  J H Vaughan; R J Jacox; P Noell
Journal:  Arthritis Rheum       Date:  1968-04

4.  The potentiating effect of rheumatoid arthritis serum in the immediate phase of nephrotoxic nephritis.

Authors:  J N McCormick; J Day; C J Morris; A G Hill
Journal:  Clin Exp Immunol       Date:  1969-01       Impact factor: 4.330

5.  Complement fixation on cell surfaces by 19S and 7S antibodies.

Authors:  T Borsos; H J Rapp
Journal:  Science       Date:  1965-10-22       Impact factor: 47.728

6.  Reversible loss of activity of the first component of complement (C'1) as a function of ionic strength.

Authors:  H R Colten; T Borsos; H J Rapp
Journal:  J Immunol       Date:  1968-04       Impact factor: 5.422

7.  Reactions of aggregated mercaptoethanol treated gamma globulin with rheumatoid factor--precipitin and complement fixation studies.

Authors:  N J Zvaifler; P Schur
Journal:  Arthritis Rheum       Date:  1968-08

8.  Hemolysin titration based on fixation of the activated first component of complement: evidence that one molecule of hemolysin suffices to sensitize an erythrocyte.

Authors:  T Borsos; H J Rapp
Journal:  J Immunol       Date:  1965-09       Impact factor: 5.422

9.  Inhibition of complementary lysis by rheumatoid sera.

Authors:  J A Romeyn; D M Bowman
Journal:  Nature       Date:  1967-10-14       Impact factor: 49.962

10.  Immunoconglutinin in various rheumatic diseases and certain diseases suspected of an autoimmune pathogenesis.

Authors:  J Bienenstock; K J Bloch
Journal:  Arthritis Rheum       Date:  1967-06
View more
  21 in total

1.  Effect of rheumatoid factor and anti-immunoglobulin G antibodies on complement-mediated lysis of herpes simplex virus-infected human fibroblasts.

Authors:  J C Shivers; C A Daniels
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

2.  A study of complement fixation by rheumatoid factor using a haemolytic assay system.

Authors:  M M Taylor-Upsahl; P M Johnson; O J Mellbye; J B Natvig
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

3.  Clinical and laboratory aspects of raised virus antibody titres in systemic lupus erythematosus.

Authors:  N F Rothfield; A S Evans; J C Niederman
Journal:  Ann Rheum Dis       Date:  1973-05       Impact factor: 19.103

4.  The roles of IgG, IgM rheumatoid factor, and their complexes in the induction of polymorphonuclear leukocyte chemotactic factor from complement.

Authors:  T Wagner; G Abraham; J Baum
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

5.  IgG antigens of the C gamma 2 and C gamma 3 homology regions interacting with rheumatoid factors.

Authors:  J B Natvig; P I Gaarder; M W Turner
Journal:  Clin Exp Immunol       Date:  1972-10       Impact factor: 4.330

6.  Apolipoprotein E Triggers Complement Activation in Joint Synovial Fluid of Rheumatoid Arthritis Patients by Binding C1q.

Authors:  Leonie M Vogt; Ewa Kwasniewicz; Simone Talens; Carsten Scavenius; Ewa Bielecka; Kristina N Ekdahl; Jan J Enghild; Matthias Mörgelin; Tore Saxne; Jan Potempa; Anna M Blom
Journal:  J Immunol       Date:  2020-04-06       Impact factor: 5.422

7.  Reduction of the complement activation capacity of soluble IgG aggregates and immune complexes by IgM-rheumatoid factor.

Authors:  G Doekes; J Schouten; A Cats; M R Daha
Journal:  Immunology       Date:  1985-07       Impact factor: 7.397

8.  Enzyme immunoassay of complement-binding rheumatoid factors.

Authors:  A M Teppo; C P Maury
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

9.  Mumps class-specific immunoglobulins in radioimmunoassay and conventional serology.

Authors:  H Daugharty; D T Warfield; W D Hemingway; H L Casey
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

10.  Association of rheumatoid factor with complement activation in rheumatoid arthritis and other diseases.

Authors:  P A Reyes; J G Maluf; J G Curd; J H Vaughan
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.